Caring Brands, Inc. (CABR)

Current Report Filed: 2026-04-10

Caring Brands, Inc. has received a delisting notice from Nasdaq due to failure to meet the minimum stockholders' equity requirement of $2.5 million, which is a compliance issue that could lead to the company being delisted from the exchange.
The company intends to submit a plan to Nasdaq within 45 days to regain compliance with the stockholders' equity rule, but there is no assurance that the plan will be accepted or that the company will be able to regain compliance within the 180-day deadline.
The delisting notice and potential delisting pose a significant risk to the company and its shareholders, as it could impact the stock's tradability and access to capital markets.

Current Report Filed: 2026-03-31

Caring Brands, Inc. (CABR) has reduced the quorum requirement for shareholder meetings from a majority to 33 1/3%, which could make it easier for the company to hold such meetings.
The company has appointed its Chief Investment Officer and Chairman of the Board, Brian John, as the Interim Chief Financial Officer, citing his proven track record in driving business growth and experience in managing publicly traded companies.
The appointment of an Interim CFO could indicate potential financial or leadership changes within the company, which investors should monitor going forward.

Annual Report Filed: 2026-03-31

Caring Brands, Inc. (CABR) has entered into several new licensing agreements and consulting services arrangements, which could provide additional revenue streams and growth opportunities.
The company has issued convertible preferred stock and common stock warrants, potentially indicating a need for additional capital or a strategic financing event.
Caring Brands has experienced changes in its executive leadership and board of directors, which could signal a shift in the company's strategic direction.

Insider Trading Filed: 2026-03-27

The reporting person, John Brian, has redeemed 1,250,000 shares of common stock of Caring Brands, Inc. (CABR) at approximately $1.00 per share, reducing his beneficial ownership to 750,000 shares.
The redemption was made pursuant to a Share Redemption Agreement signed on March 19, 2026, suggesting a planned transaction.
The timing and the magnitude of the share redemption may indicate a change in the reporting person's investment strategy or financial needs.

Insider Trading Filed: 2026-03-27

The reporting person, Dr. Glynn Wilson, has redeemed 1.5 million shares of Caring Brands, Inc. common stock at $0.50 per share, reducing his beneficial ownership to 672,592 shares.
Dr. Wilson holds 126,720 restricted stock units and 45,872 restricted stock units, none of which have vested, in addition to the 500,000 shares of common stock he owns.
The share redemption represents a significant reduction in Dr. Wilson's equity ownership in the company, which could signal a change in his commitment or future plans for the company.

Current Report Filed: 2026-03-24

Caring Brands raised $3.6 million in a PIPE offering, issuing 3.8 million shares of Series A Convertible Preferred Stock and 9.5 million warrants. The proceeds will be used to retire 6.25 million shares of common stock held by insiders.
The PIPE offering provides Caring Brands with additional capital to fund operations and strategic initiatives, while reducing the total outstanding shares of common stock through the insider share redemptions.
Caring Brands granted the PIPE investor the right to purchase up to an additional $4 million of Series A Preferred Stock and Warrants, providing potential for further capital raises on favorable terms for the company.

Current Report Filed: 2026-02-03

Caring Brands, Inc. has been granted two new U.S. patents related to its proprietary Hair Enzyme Booster product, strengthening the company's intellectual property portfolio.
The company is an emerging growth company, indicating it is in an early stage of development and may be subject to higher risk but also higher growth potential.
The company's principal executive offices are located in Fort Pierce, Florida, which could impact its operational and financial performance depending on local economic conditions.

Current Report Filed: 2026-01-09

The Chief Financial Officer, Tyler Moore, has resigned from Caring Brands, Inc. This leadership change could signal potential changes in the company's financial strategy or management.
Caring Brands, Inc. has commenced a search for a new Chief Financial Officer, indicating the company is actively working to fill this key role in the near term.
The company stated that Mr. Moore's resignation was not due to any disagreement on the company's operations, policies, or practices, suggesting an amicable departure.

Current Report Filed: 2026-01-05

Caring Brands has entered into an exclusive, worldwide license agreement with Itonis Pharmaceuticals to manufacture, market and sell Itonis's homeopathic Emesyl product, which could provide a new revenue stream for the company.
The license agreement includes a royalty of 8% of net sales for Caring Brands, as well as the potential for Caring Brands to receive 7% of Itonis's equity for every $200,000 in product sales, incentivizing the successful commercialization of the product.
The license agreement includes provisions for termination if product sales fall below $25,000 for four consecutive quarters, which poses a risk if the Emesyl product fails to gain traction in the market.

Important Information